| Product Code: ETC5634903 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Cancer Biomarkers Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Cancer Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Cancer Biomarkers Market - Industry Life Cycle |
3.4 Taiwan Cancer Biomarkers Market - Porter's Five Forces |
3.5 Taiwan Cancer Biomarkers Market Revenues & Volume Share, By Biomarkers Type, 2021 & 2031F |
3.6 Taiwan Cancer Biomarkers Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Taiwan Cancer Biomarkers Market Revenues & Volume Share, By Profiling Technologies, 2021 & 2031F |
3.8 Taiwan Cancer Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Taiwan Cancer Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Taiwan |
4.2.2 Growing adoption of precision medicine and personalized treatment |
4.2.3 Government initiatives to promote cancer biomarker research and development |
4.3 Market Restraints |
4.3.1 High cost associated with cancer biomarker testing |
4.3.2 Limited awareness and understanding of cancer biomarkers among healthcare professionals and patients |
5 Taiwan Cancer Biomarkers Market Trends |
6 Taiwan Cancer Biomarkers Market Segmentations |
6.1 Taiwan Cancer Biomarkers Market, By Biomarkers Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Cancer Biomarkers Market Revenues & Volume, By Protein Biomarkers, 2021-2031F |
6.1.3 Taiwan Cancer Biomarkers Market Revenues & Volume, By Genetic Biomarkers, 2021-2031F |
6.1.4 Taiwan Cancer Biomarkers Market Revenues & Volume, By Other Cancer Biomarkers, 2021-2031F |
6.2 Taiwan Cancer Biomarkers Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Cancer Biomarkers Market Revenues & Volume, By Breast Cancer, 2021-2031F |
6.2.3 Taiwan Cancer Biomarkers Market Revenues & Volume, By Lung Cancer, 2021-2031F |
6.2.4 Taiwan Cancer Biomarkers Market Revenues & Volume, By Colorectal Cancer, 2021-2031F |
6.2.5 Taiwan Cancer Biomarkers Market Revenues & Volume, By Prostate Cancer, 2021-2031F |
6.2.6 Taiwan Cancer Biomarkers Market Revenues & Volume, By Melanoma, 2021-2031F |
6.2.7 Taiwan Cancer Biomarkers Market Revenues & Volume, By Leukemia, 2021-2031F |
6.2.8 Taiwan Cancer Biomarkers Market Revenues & Volume, By Bladder Cancer, 2021-2031F |
6.2.9 Taiwan Cancer Biomarkers Market Revenues & Volume, By Bladder Cancer, 2021-2031F |
6.3 Taiwan Cancer Biomarkers Market, By Profiling Technologies |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Cancer Biomarkers Market Revenues & Volume, By Omics Technologies, 2021-2031F |
6.3.3 Taiwan Cancer Biomarkers Market Revenues & Volume, By Imaging Technologies, 2021-2031F |
6.3.4 Taiwan Cancer Biomarkers Market Revenues & Volume, By Immunoassay, 2021-2031F |
6.3.5 Taiwan Cancer Biomarkers Market Revenues & Volume, By Bioinformatics, 2021-2031F |
6.3.6 Taiwan Cancer Biomarkers Market Revenues & Volume, By Cytogenetics, 2021-2031F |
6.4 Taiwan Cancer Biomarkers Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Cancer Biomarkers Market Revenues & Volume, By Diagnostics, 2021-2031F |
6.4.3 Taiwan Cancer Biomarkers Market Revenues & Volume, By Research & Development, 2021-2031F |
6.4.4 Taiwan Cancer Biomarkers Market Revenues & Volume, By Prognostics, 2021-2031F |
6.4.5 Taiwan Cancer Biomarkers Market Revenues & Volume, By Risk Assessment, 2021-2031F |
6.4.6 Taiwan Cancer Biomarkers Market Revenues & Volume, By Other Applications, 2021-2031F |
7 Taiwan Cancer Biomarkers Market Import-Export Trade Statistics |
7.1 Taiwan Cancer Biomarkers Market Export to Major Countries |
7.2 Taiwan Cancer Biomarkers Market Imports from Major Countries |
8 Taiwan Cancer Biomarkers Market Key Performance Indicators |
8.1 Number of clinical trials incorporating cancer biomarkers in Taiwan |
8.2 Percentage increase in research funding for cancer biomarkers |
8.3 Adoption rate of new cancer biomarker tests by healthcare providers |
9 Taiwan Cancer Biomarkers Market - Opportunity Assessment |
9.1 Taiwan Cancer Biomarkers Market Opportunity Assessment, By Biomarkers Type, 2021 & 2031F |
9.2 Taiwan Cancer Biomarkers Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Taiwan Cancer Biomarkers Market Opportunity Assessment, By Profiling Technologies, 2021 & 2031F |
9.4 Taiwan Cancer Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Taiwan Cancer Biomarkers Market - Competitive Landscape |
10.1 Taiwan Cancer Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Cancer Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |